Genapsys Adds to its Leadership Team with Two New Hires
September 9, 2021
REDWOOD CITY, Calif. — Genapsys, Inc. (Genapsys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of Priya Ray and Peter Swider to the Company’s leadership team as well as the launch of the company’s new branding and corporate website, www.genapsys.com. “We are pleased to welcome Priya and Peter [...]
OpenEye Scientific Partners with Enamine to Accelerate Early Drug Discovery
September 9, 2021
SANTA FE, N.M., USA, & KYIV, Ukraine – OpenEye Scientific and Enamine, a leading global provider of billions of new screening compounds to the drug discovery market, are partnering to enable faster and more accurate virtual screening of ultra-large compound libraries through access to innovative software. Using Orion®, OpenEye’s cloud-native molecular design platform, scientists can: [...]
September 9, 2021
BOSTON -- Seven Bridges, the industry-leading bioinformatics ecosystem provider, and Scripps Research have been awarded a $7.5M contract to develop a federated data ecosystem for the National Institute of Allergy and Infectious Diseases (NIAID) under a project titled the NIAID Data Ecosystem (NDE). The NDE will be a secure environment to find, access, query and analyze data from select NIAID repositories, [...]
September 9, 2021
Seattle, WA – RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and existing investors. The funding will drive the commercialization and applications for the Company’s new Orion spatial biology platform and further global expansion [...]
Cytiva triples single-use consumables capacity in China
September 9, 2021
Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. Sustain and secure the supply chain for customers in China and the broader region. With the use of Fortem™ film, Cytiva helps customers speed up their clinical manufacturing and product launches; improve manufacturing [...]
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
September 9, 2021
– Research collaboration covers multiple antibody research programs – SOUTH SAN FRANCISCO, Calif. & INGELHEIM, Germany -- Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twist’s proprietary antibody libraries [...]
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
September 9, 2021
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) elevates climate action goals with commitments for net zero greenhouse gas emissions aligned with the Paris Agreement, commits to verified Science Based Targets, signs the Business Ambition for 1.5 degree and joins the United Nations campaign Race to Zero. "Human health and the health of our environment are intertwined. At Illumina, [...]
September 9, 2021
WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), today announced they have completed development and validation of a novel protein A ligand that overcomes challenges associated with the purification of pH sensitive antibodies and Fc-fusion proteins. Named NGL-Impact® A Hi pH, the new ligand [...]
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia to the Board of Directors
September 9, 2021
Kadia joins Board as an Independent Director who brings significant expertise in commercializing disruptive life science technologies EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021. “I am excited [...]
Optibrium Releases 3D Ligand-based Design Module for StarDrop Drug Discovery Software
September 9, 2021
Innovative predictive methods support virtual screening and compound design in the absence of 3D structure data CAMBRIDGE, UK: Optibrium Ltd, a developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, optimisation and data analysis. StarDrop is used by more than 160 [...]

